MARK3 and endometrial cancer: Figure 2A visualization effectively illustrates the differential expression of MARK3 among the various different cell lines. The increased expression levels, which are statistically significant (p < 0.05), indicate that MARK3 is over expressed in endometrial cancer cell lines.